Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
PUT
America Movil
AMX
$70.3B
| $120K | ﹤0.01% |
7,500
+800
| +12% | +$13.5K |
|
5302
PUT
DTE Energy
DTE
$28.6B
| $120K | ﹤0.01% |
1,293
+118
| +10% | +$11K |
|
5303
Heritage Insurance Holdings
HRTG
$957M
| $120K | ﹤0.01% |
8,129
-14,685
| -64% | -$232K |
|
5304
Western New England Bancorp
WNEB
$281M
| $120K | ﹤0.01% |
11,162
+9,019
| +421% | +$97.7K |
|
|
CVLY
5305
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $120K | ﹤0.01% |
4,198
+3,499
| +501% | +$98.8K |
|
|
CS
5306
PUT
DELISTED
Credit Suisse Group
CS
| $120K | ﹤0.01% |
8,000
-10,400
| -57% | -$159K |
|
|
VWTR
5307
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $120K | ﹤0.01% |
9,536
-1,435
| -13% | -$17.7K |
|
|
CZZ
5308
DELISTED
Cosan Limited
CZZ
| $120K | ﹤0.01% |
17,900
-10,300
| -37% | -$75.9K |
|
|
PER
5309
DELISTED
SANDRIDGE PERMIAN TRUST
PER
| $120K | ﹤0.01% |
+45,302
| New | +$120K |
|
|
GSH
5310
DELISTED
Guangshen Railway Co. Ltd
GSH
| $120K | ﹤0.01% |
5,193
+5,100
| +5,484% | +$122K |
|
5311
Artesian Resources
ARTNA
$362M
| $118K | ﹤0.01% |
3,222
+2,111
| +190% | +$78.6K |
|
5312
IDT Corp
IDT
$1.63B
| $118K | ﹤0.01% |
22,020
-2,142
| -9% | -$11.5K |
|
|
ACOR
5313
CALL
DELISTED
Acorda Therapeutics
ACOR
| $118K | ﹤0.01% |
50
+40
| +400% | +$124K |
|
|
MLNX
5314
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $118K | ﹤0.01% |
1,600
-1,400
| -47% | -$113K |
|
|
BKS
5315
PUT
DELISTED
Barnes & Noble
BKS
| $118K | ﹤0.01% |
20,300
+19,900
| +4,975% | +$112K |
|
5316
Alto Ingredients
ALTO
$323M
| $117K | ﹤0.01% |
60,985
-16,146
| -21% | -$36.1K |
|
5317
Hurco Companies Inc
HURC
$143M
| $117K | ﹤0.01% |
2,586
+2,131
| +468% | +$93.6K |
|
5318
Ooma
OOMA
$578M
| $117K | ﹤0.01% |
7,045
+5,577
| +380% | +$89.5K |
|
|
RC
5319
Ready Capital
RC
$323M
| $117K | ﹤0.01% |
7,062
+5,769
| +446% | +$96.4K |
|
5320
CALL
RPM International
RPM
$14.9B
| $117K | ﹤0.01% |
1,800
+400
| +29% | +$25.8K |
|
|
5321
PUT
RPM International
RPM
$14.9B
| $117K | ﹤0.01% |
1,800
+1,700
| +1,700% | +$109K |
|
|
PRTK
5322
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $117K | ﹤0.01% |
11,975
+9,611
| +407% | +$96.9K |
|
|
ALBO
5323
DELISTED
Albireo Pharma Inc
ALBO
| $117K | ﹤0.01% |
3,528
+2,861
| +429% | +$93.6K |
|
5324
Ares Management
ARES
$32.3B
| $116K | ﹤0.01% |
5,000
-5,627
| -53% | -$121K |
|
5325
PUT
IMAX
IMAX
$2.77B
| $116K | ﹤0.01% |
4,500
-9,700
| -68% | -$228K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.